Global Biologics Contract Manufacturing Market Research Report 2022
SKU ID :QYR-20858023 | Published Date: 06-May-2022 | No. of pages: 86Description
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Vaccines
1.2.5 Molecular Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biologics Contract Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Medical Company
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Manufacturing Market Perspective (2017-2028)
2.2 Biologics Contract Manufacturing Growth Trends by Region
2.2.1 Biologics Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biologics Contract Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Biologics Contract Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Biologics Contract Manufacturing Market Dynamics
2.3.1 Biologics Contract Manufacturing Industry Trends
2.3.2 Biologics Contract Manufacturing Market Drivers
2.3.3 Biologics Contract Manufacturing Market Challenges
2.3.4 Biologics Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Contract Manufacturing Players by Revenue
3.1.1 Global Top Biologics Contract Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Contract Manufacturing Revenue
3.4 Global Biologics Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biologics Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Manufacturing Revenue in 2021
3.5 Biologics Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Biologics Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biologics Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Manufacturing Breakdown Data by Type
4.1 Global Biologics Contract Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Biologics Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Biologics Contract Manufacturing Breakdown Data by Application
5.1 Global Biologics Contract Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Biologics Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biologics Contract Manufacturing Market Size (2017-2028)
6.2 North America Biologics Contract Manufacturing Market Size by Country (2017-2022)
6.3 North America Biologics Contract Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biologics Contract Manufacturing Market Size (2017-2028)
7.2 Europe Biologics Contract Manufacturing Market Size by Country (2017-2022)
7.3 Europe Biologics Contract Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Contract Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Biologics Contract Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biologics Contract Manufacturing Market Size (2017-2028)
9.2 Latin America Biologics Contract Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Biologics Contract Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Contract Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Detail
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biologics Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.1.5 Lonza Group Recent Development
11.2 Samsung Biologics Co., Ltd.
11.2.1 Samsung Biologics Co., Ltd. Company Detail
11.2.2 Samsung Biologics Co., Ltd. Business Overview
11.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Introduction
11.2.4 Samsung Biologics Co., Ltd. Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.2.5 Samsung Biologics Co., Ltd. Recent Development
11.3 Thermo Fisher Scientific, Inc.
11.3.1 Thermo Fisher Scientific, Inc. Company Detail
11.3.2 Thermo Fisher Scientific, Inc. Business Overview
11.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Introduction
11.3.4 Thermo Fisher Scientific, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.3.5 Thermo Fisher Scientific, Inc. Recent Development
11.4 Cambrex Corporation
11.4.1 Cambrex Corporation Company Detail
11.4.2 Cambrex Corporation Business Overview
11.4.3 Cambrex Corporation Biologics Contract Manufacturing Introduction
11.4.4 Cambrex Corporation Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.4.5 Cambrex Corporation Recent Development
11.5 Siegfried Holding AG
11.5.1 Siegfried Holding AG Company Detail
11.5.2 Siegfried Holding AG Business Overview
11.5.3 Siegfried Holding AG Biologics Contract Manufacturing Introduction
11.5.4 Siegfried Holding AG Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.5.5 Siegfried Holding AG Recent Development
11.6 Fujifilm Holding Corporation
11.6.1 Fujifilm Holding Corporation Company Detail
11.6.2 Fujifilm Holding Corporation Business Overview
11.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Introduction
11.6.4 Fujifilm Holding Corporation Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.6.5 Fujifilm Holding Corporation Recent Development
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Detail
11.7.2 AbbVie, Inc. Business Overview
11.7.3 AbbVie, Inc. Biologics Contract Manufacturing Introduction
11.7.4 AbbVie, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.7.5 AbbVie, Inc. Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Introduction
11.8.4 Boehringer Ingelheim Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Recipharm Pharmaceuticals
11.9.1 Recipharm Pharmaceuticals Company Detail
11.9.2 Recipharm Pharmaceuticals Business Overview
11.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Introduction
11.9.4 Recipharm Pharmaceuticals Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.9.5 Recipharm Pharmaceuticals Recent Development
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Detail
11.10.2 WuXi Biologics Business Overview
11.10.3 WuXi Biologics Biologics Contract Manufacturing Introduction
11.10.4 WuXi Biologics Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.10.5 WuXi Biologics Recent Development
11.11 Catalent, Inc.
11.11.1 Catalent, Inc. Company Detail
11.11.2 Catalent, Inc. Business Overview
11.11.3 Catalent, Inc. Biologics Contract Manufacturing Introduction
11.11.4 Catalent, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022)
11.11.5 Catalent, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables & Figures
List of Tables
Table 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Recombinant Proteins
Table 4. Key Players of Vaccines
Table 5. Key Players of Molecular Therapy
Table 6. Key Players of Others
Table 7. Global Biologics Contract Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Biologics Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Biologics Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Biologics Contract Manufacturing Market Share by Region (2017-2022)
Table 11. Global Biologics Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Biologics Contract Manufacturing Market Share by Region (2023-2028)
Table 13. Biologics Contract Manufacturing Market Trends
Table 14. Biologics Contract Manufacturing Market Drivers
Table 15. Biologics Contract Manufacturing Market Challenges
Table 16. Biologics Contract Manufacturing Market Restraints
Table 17. Global Biologics Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Biologics Contract Manufacturing Market Share by Players (2017-2022)
Table 19. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2021)
Table 20. Ranking of Global Top Biologics Contract Manufacturing Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Biologics Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biologics Contract Manufacturing Product Solution and Service
Table 24. Date of Enter into Biologics Contract Manufacturing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologics Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Biologics Contract Manufacturing Revenue Market Share by Type (2017-2022)
Table 28. Global Biologics Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Biologics Contract Manufacturing Revenue Market Share by Type (2023-2028)
Table 30. Global Biologics Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Biologics Contract Manufacturing Revenue Market Share by Application (2017-2022)
Table 32. Global Biologics Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Biologics Contract Manufacturing Revenue Market Share by Application (2023-2028)
Table 34. North America Biologics Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Biologics Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Biologics Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Biologics Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Biologics Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Biologics Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 44. Lonza Group Company Detail
Table 45. Lonza Group Business Overview
Table 46. Lonza Group Biologics Contract Manufacturing Product
Table 47. Lonza Group Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 48. Lonza Group Recent Development
Table 49. Samsung Biologics Co., Ltd. Company Detail
Table 50. Samsung Biologics Co., Ltd. Business Overview
Table 51. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product
Table 52. Samsung Biologics Co., Ltd. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 53. Samsung Biologics Co., Ltd. Recent Development
Table 54. Thermo Fisher Scientific, Inc. Company Detail
Table 55. Thermo Fisher Scientific, Inc. Business Overview
Table 56. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product
Table 57. Thermo Fisher Scientific, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 58. Thermo Fisher Scientific, Inc. Recent Development
Table 59. Cambrex Corporation Company Detail
Table 60. Cambrex Corporation Business Overview
Table 61. Cambrex Corporation Biologics Contract Manufacturing Product
Table 62. Cambrex Corporation Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 63. Cambrex Corporation Recent Development
Table 64. Siegfried Holding AG Company Detail
Table 65. Siegfried Holding AG Business Overview
Table 66. Siegfried Holding AG Biologics Contract Manufacturing Product
Table 67. Siegfried Holding AG Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 68. Siegfried Holding AG Recent Development
Table 69. Fujifilm Holding Corporation Company Detail
Table 70. Fujifilm Holding Corporation Business Overview
Table 71. Fujifilm Holding Corporation Biologics Contract Manufacturing Product
Table 72. Fujifilm Holding Corporation Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 73. Fujifilm Holding Corporation Recent Development
Table 74. AbbVie, Inc. Company Detail
Table 75. AbbVie, Inc. Business Overview
Table 76. AbbVie, Inc. Biologics Contract Manufacturing Product
Table 77. AbbVie, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 78. AbbVie, Inc. Recent Development
Table 79. Boehringer Ingelheim Company Detail
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Biologics Contract Manufacturing Product
Table 82. Boehringer Ingelheim Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Development
Table 84. Recipharm Pharmaceuticals Company Detail
Table 85. Recipharm Pharmaceuticals Business Overview
Table 86. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product
Table 87. Recipharm Pharmaceuticals Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 88. Recipharm Pharmaceuticals Recent Development
Table 89. WuXi Biologics Company Detail
Table 90. WuXi Biologics Business Overview
Table 91. WuXi Biologics Biologics Contract Manufacturing Product
Table 92. WuXi Biologics Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 93. WuXi Biologics Recent Development
Table 94. Catalent, Inc. Company Detail
Table 95. Catalent, Inc. Business Overview
Table 96. Catalent, Inc. Biologics Contract ManufacturingProduct
Table 97. Catalent, Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 98. Catalent, Inc. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Contract Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Monoclonal Antibodies Features
Figure 3. Recombinant Proteins Features
Figure 4. Vaccines Features
Figure 5. Molecular Therapy Features
Figure 6. Others Features
Figure 7. Global Biologics Contract Manufacturing Market Share by Application in 2021 & 2028
Figure 8. Medical Company Case Studies
Figure 9. Hospital Case Studies
Figure 10. Biologics Contract Manufacturing Report Years Considered
Figure 11. Global Biologics Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Biologics Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Biologics Contract Manufacturing Market Share by Region: 2021 VS 2028
Figure 14. Global Biologics Contract Manufacturing Market Share by Players in 2021
Figure 15. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Biologics Contract Manufacturing Revenue in 2021
Figure 17. North America Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Biologics Contract Manufacturing Market Share by Country (2017-2028)
Figure 19. United States Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Biologics Contract Manufacturing Market Share by Country (2017-2028)
Figure 23. Germany Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Biologics Contract Manufacturing Market Share by Region (2017-2028)
Figure 31. China Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Biologics Contract Manufacturing Market Share by Country (2017-2028)
Figure 39. Mexico Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Biologics Contract Manufacturing Market Share by Country (2017-2028)
Figure 43. Turkey Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Biologics Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Lonza Group Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 46. Samsung Biologics Co., Ltd. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 47. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 48. Cambrex Corporation Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 49. Siegfried Holding AG Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 50. Fujifilm Holding Corporation Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 51. AbbVie, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 53. Recipharm Pharmaceuticals Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 54. WuXi Biologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 55. Catalent, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Companies
Lonza Group
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.
- PRICE
-
$2900$5800$4350Buy Now